Search - tctmd.com

Displaying 1 - 20 of 171

Sort: Relevancy | Date

News Daily News

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Michael O'Riordan

January 22, 2026

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

Todd Neale

November 03, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Todd Neale

December 19, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Daily News

Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs

L.A. McKeown

August 15, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Conference News SCAI 2024

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

L.A. McKeown

May 03, 2024

News Conference News SCAI 2024

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

L.A. McKeown

May 02, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Daily News

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Michael O'Riordan

January 25, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

Advertisement

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

What’s Going to Be Hot at TCT 2025

Top Structural Heart News of 2024

Top Endovascular News of 2024

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

FDA Approves Bioresorbable Scaffold for BTK Lesions

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Top Endovascular News of 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content